Ilia V Baskakov

Author PubWeight™ 74.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Synthetic mammalian prions. Science 2004 7.35
2 Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 2010 3.19
3 In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J Mol Biol 2004 2.59
4 Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A 2009 2.41
5 Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci U S A 2005 2.25
6 Protease-sensitive synthetic prions. PLoS Pathog 2010 2.14
7 The same primary structure of the prion protein yields two distinct self-propagating states. J Biol Chem 2008 1.64
8 Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease. Protein Sci 2005 1.62
9 The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry 2010 1.53
10 Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathog 2011 1.53
11 Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J Biol Chem 2006 1.47
12 Highly efficient protein misfolding cyclic amplification. PLoS Pathog 2011 1.46
13 Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy. J Mol Biol 2006 1.44
14 Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core. J Biol Chem 2005 1.44
15 Conformational switching within individual amyloid fibrils. J Biol Chem 2009 1.31
16 Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochemistry 2005 1.28
17 Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size. J Mol Biol 2008 1.27
18 A new mechanism for transmissible prion diseases. J Neurosci 2012 1.25
19 Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation. Biochemistry 2005 1.25
20 Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay. J Biol Chem 2006 1.22
21 Two amyloid States of the prion protein display significantly different folding patterns. J Mol Biol 2010 1.16
22 Site-specific conformational studies of prion protein (PrP) amyloid fibrils revealed two cooperative folding domains within amyloid structure. J Biol Chem 2007 1.14
23 Stabilization of a prion strain of synthetic origin requires multiple serial passages. J Biol Chem 2012 1.13
24 Highly promiscuous nature of prion polymerization. J Biol Chem 2007 1.12
25 Relationship between conformational stability and amplification efficiency of prions. Biochemistry 2011 1.11
26 Chemoenzymatic synthesis of HIV-1 V3 glycopeptides carrying two N-glycans and effects of glycosylation on the peptide domain. J Org Chem 2005 1.06
27 Dichotomous versus palm-type mechanisms of lateral assembly of amyloid fibrils. Protein Sci 2006 1.04
28 Fast and ultrasensitive method for quantitating prion infectivity titre. Nat Commun 2012 1.01
29 The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP. J Mol Biol 2008 1.01
30 Changes in prion replication environment cause prion strain mutation. FASEB J 2013 0.99
31 Methods for conversion of prion protein into amyloid fibrils. Methods Mol Biol 2008 0.98
32 Light-dependent electrogenic activity of cyanobacteria. PLoS One 2010 0.98
33 Expression and purification of full-length recombinant PrP of high purity. Methods Mol Biol 2008 0.97
34 The dominant-negative effect of the Q218K variant of the prion protein does not require protein X. Protein Sci 2007 0.96
35 Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification. J Biol Chem 2012 0.96
36 Assessment of strain-specific PrP(Sc) elongation rates revealed a transformation of PrP(Sc) properties during protein misfolding cyclic amplification. PLoS One 2012 0.95
37 Neuronal low-density lipoprotein receptor-related protein 1 binds and endocytoses prion fibrils via receptor cluster 4. J Cell Sci 2010 0.94
38 The evolution of transmissible prions: the role of deformed templating. PLoS Pathog 2013 0.91
39 The cellular form of the prion protein is involved in controlling cell cycle dynamics, self-renewal, and the fate of human embryonic stem cell differentiation. J Neurochem 2012 0.89
40 Nonpolar substitution at the C-terminus of the prion protein, a mimic of the glycosylphosphatidylinositol anchor, partially impairs amyloid fibril formation. Biochemistry 2007 0.89
41 Molecular structure of amyloid fibrils controls the relationship between fibrillar size and toxicity. PLoS One 2011 0.89
42 Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity. J Neurosci 2011 0.88
43 Hemicentin assembly in the extracellular matrix is mediated by distinct structural modules. J Biol Chem 2006 0.88
44 Dissecting structure of prion amyloid fibrils by hydrogen-deuterium exchange ultraviolet Raman spectroscopy. J Phys Chem B 2012 0.87
45 Treatment with normal prion protein delays differentiation and helps to maintain high proliferation activity in human embryonic stem cells. J Neurochem 2010 0.87
46 Amyloid features and neuronal toxicity of mature prion fibrils are highly sensitive to high pressure. J Biol Chem 2011 0.85
47 Amyloid fibrils of mammalian prion protein induce axonal degeneration in NTERA2-derived terminally differentiated neurons. J Neurochem 2007 0.84
48 Genesis of tramsmissible protein states via deformed templating. Prion 2012 0.84
49 Photosynthetic microbial fuel cells with positive light response. Biotechnol Bioeng 2009 0.83
50 Role of the photosynthetic electron transfer chain in electrogenic activity of cyanobacteria. Appl Microbiol Biotechnol 2011 0.82
51 Semiautomated cell-free conversion of prion protein: applications for high-throughput screening of potential antiprion drugs. Anal Biochem 2005 0.82
52 Water-soluble hybrid nanoclusters with extra bright and photostable emissions: a new tool for biological imaging. Biophys J 2005 0.81
53 Synthesis, conformation, and immunogenicity of monosaccharide-centered multivalent HIV-1 gp41 peptides containing the sequence of DP178. Bioorg Med Chem 2004 0.81
54 The cellular form of the prion protein guides the differentiation of human embryonic stem cells into neuron-, oligodendrocyte-, and astrocyte-committed lineages. Prion 2014 0.80
55 Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles. Am J Pathol 2013 0.79
56 Ubiquitination-induced fluorescence complementation (UiFC) for detection of K48 ubiquitin chains in vitro and in live cells. PLoS One 2013 0.79
57 Nanostructured polypyrrole-coated anode for sun-powered microbial fuel cells. Bioelectrochemistry 2009 0.78
58 Atomic force fluorescence microscopy in the characterization of amyloid fibril assembly and oligomeric intermediates. Methods Mol Biol 2012 0.77
59 Purification and fibrillation of full-length recombinant PrP. Methods Mol Biol 2012 0.76